Comparison CRISPR Therapeutics (CRSP) with Competitors
CRISPR Therapeutics (CRSP) industry is Biotechnology.
Operating Margin
CRSP-8933.00%
Industry-2055.25%
Upside-6877.75%
Debt-to-Equity
CRSP32.27%
Industry28.27%
Upside+14.14%
Free Cash Flow Yield
CRSP-8.10%
Industry-1.75%
Upside-6.36%
P/E
CRSP-8.38
Industry-20.52
Upside+1213.87%
Forward P/E
CRSP23.36
Industry16.35
Upside+42.88%
P/S
CRSP1211.19
Industry10.01
Upside+11995.53%
P/B
CRSP2.74
Industry5.15
Upside-46.78%